BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• Business

  Blavatnik Biomedical Accelerator At Harvard Announces License And Collaboration Agreement With Merck To Develop Novel Cancer Therapeutics

  March 21, 2016

   · 

  4 min read
• FDA

  Stentys Announces The CE Marking Of The Self-Apposing Stent For Left Main Coronary Artery Disease

  March 21, 2016

   · 

  3 min read
• Drug Development

  Celgene Release: Oral Ozanimod Showed Histologic Improvements In Patients With Ulcerative Colitis In The Phase 2 TOUCHSTONE Trial

  March 21, 2016

   · 

  7 min read
• Business

  BioStem Technologies (OTC: BSEM) Appoints New Members To Its Board Of Directors

  March 21, 2016

   · 

  3 min read
• FDA

  Horizon Pharma Receives Health Canada Approval For RAVICTI (Glycerol Phenylbutyrate) Oral Liquid For The Treatment Of Urea Cycle Disorders In Patients Two Years Of Age And Older

  March 21, 2016

   · 

  6 min read
• Drug Development

  Ritter Pharmaceuticals, Inc. Doses First Patient In Phase 2b/3 Trial Of RP-G28 In Lactose Intolerance

  March 21, 2016

   · 

  2 min read
• Business

  Arzeda And Zymergen Collaborate On Development Of New Molecules

  March 21, 2016

   · 

  2 min read
• Deals

  Affymetrix (Santa Clara, California) Rejects $1.5 Billion Rival Takeover Bid, Favors Thermo Fisher Scientific

  March 21, 2016

   · 

  7 min read
• Led by Founders of Salix, Atlantic Healthcare Locks in $24 Million Financing

  March 21, 2016

   · 

  8 min read
• Business

  AVEO Oncology, CANBridge Life Sciences Strike $134 Million Deal for AV-203

  March 21, 2016

   · 

  7 min read